(Q44343438)

2 December 2017

Stress-opioid interactions: a comparison of morphine and methadone (English)

1 reference

2 December 2017

0 references

Adam Hamed

7

0 references

Anna Skórzewska

Anna Skórzewska

8

0 references

Ewa Taracha

Ewa Taracha

1

0 references

Małgorzata H Lehner

Małgorzata Lehner

3

0 references

Stanisław J Chrapusta

Stanisław J Chrapusta

4

0 references

Adam Płaźnik

10

Adam Płaźnik

1 reference

2 December 2017

9

Wojciech Kostowski

1 reference

2 December 2017

2

Paweł Mierzejewski

1 reference

2 December 2017

Maria Kała

5

1 reference

PubMed ID

19605941

2 December 2017

Wojciech Lechowicz

6

1 reference

2 December 2017

1 May 2009

1 reference

2 December 2017

Pharmacological Reports

1 reference

2 December 2017

61

1 reference

2 December 2017

3

1 reference

2 December 2017

424-435

1 reference

Formation and clearance of active and inactive metabolites of opiates in humans

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Catalepsy and stereotypies in rats treated with methadone; Relation to striatal dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Modulation of morphine sensitization in the rat by contextual stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Effects of beta-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Potentiation of morphine analgesia by BQ123, an endothelin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Stress potentiation of morphine-induced dopamine efflux in the nucleus accumbens shell is dependent upon stressor uncontrollability and is mediated by the dorsal raphe nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Morphine activation of c-fos expression in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Morphine-induced c-fos mRNA expression in striatofugal circuits: modulation by dose, environmental context, and drug history

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Chronic administration of morphine alters immediate-early gene expression in the forebrain of post-dependent rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Advances in opioid pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

An opiate cocktail that reduces morphine tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Drug addiction: pathways to the disease and pathophysiological perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Behavioral, immunocytochemical and biochemical studies in rats differing in their sensitivity to pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Mild stress sensitizes the brain's response to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Quantitation of methadone enantiomers in humans using stable isotope-labeled [2H3]-, [2H5]-, and [2H8]Methadone

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Modulatory effect of environmental context and drug history on heroin-induced psychomotor activity and fos protein expression in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Differential disappearance of tolerance to thermal, hormonal and locomotor effects of morphine in the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Expression of c-fos protein in brain: metabolic mapping at the cellular level

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

Regional mu opioid receptor regulation of sensory and affective dimensions of pain

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970083-0

7 January 2021

10.1016/S1734-1140(09)70083-0

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

19605941